you are here: Home News Abbott

Abbott

Abbott India shares gain after company assures fixing issues at Goa Plant
Short Call | Inflation a spoilsport; bulletproof fluorochems; Voltas, Abbot, Bata, Vedanta in focus
How Abbott is bringing together groups to quickly identify viral threats in India, world
Telangana drug sleuths to crack down on large counterfeit drug cartels
Abbott baby formula plant again stops production, this time because of flooding
FDA and Abbott reach agreement on baby formula to try to ease shortage
Syngene: Heavy investment phase makes it a long-term play
Abbott launches continuous blood glucose monitoring system FreeStyle Libre in India
Coronavirus update: Abbott's card-sized 15-minute COVID-19 test gets US FDA nod for emergency use
Abbott launches quadrivalent vaccine for influenza in India
Unable to buy Limcee Vitamin-C tablets from medical stores? Blame it on China
Abbott takes digital route in India to improve patient health outcomes
Abbott discontinues selling Xience Alpine stents in India
Abbott increases nutrition portfolio for metabolic disorders
Havas Group acquires healthcare agency Sorento
Stocks in the news: Tata Steel, Golden Tobacco, Lupin, Capital First, IRB Infra
Under cost pressure, Abbott to urge NPPA to allow withdrawal of stents again
Indian drug market grows at 9.6% in March on waning demonetisation effect
In last 5 years midcaps have outperformed Nifty by 50%; will the rally continue?
Stents to get cheaper by as much as 85% as drug body caps price
Sebi fines Piramal Ent for lapses on insider trade control
Biosimilar insulin Glargine to make $100 m from FY18: Biocon
Realty reportcard: The flashback and road ahead for 2016
Godrej Prop's debt now halved due to BKC asset sale: CLSA
Godrej Prop sells its BKC project for Rs 1,479cr to Abbott

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Abbott

Abbott India shares gain after company assures fixing issues at Goa Plant

Short Call | Inflation a spoilsport; bulletproof fluorochems; Voltas, Abbot, Bata, Vedanta in focus

How Abbott is bringing together groups to quickly identify viral threats in India, world

Telangana drug sleuths to crack down on large counterfeit drug cartels

Abbott baby formula plant again stops production, this time because of flooding

FDA and Abbott reach agreement on baby formula to try to ease shortage

Syngene: Heavy investment phase makes it a long-term play

Abbott launches continuous blood glucose monitoring system FreeStyle Libre in India

Coronavirus update: Abbott's card-sized 15-minute COVID-19 test gets US FDA nod for emergency use

Abbott launches quadrivalent vaccine for influenza in India

Unable to buy Limcee Vitamin-C tablets from medical stores? Blame it on China

Abbott takes digital route in India to improve patient health outcomes

Abbott discontinues selling Xience Alpine stents in India

Abbott increases nutrition portfolio for metabolic disorders

Havas Group acquires healthcare agency Sorento

Stocks in the news: Tata Steel, Golden Tobacco, Lupin, Capital First, IRB Infra

Under cost pressure, Abbott to urge NPPA to allow withdrawal of stents again

Indian drug market grows at 9.6% in March on waning demonetisation effect

In last 5 years midcaps have outperformed Nifty by 50%; will the rally continue?

Stents to get cheaper by as much as 85% as drug body caps price

Sebi fines Piramal Ent for lapses on insider trade control

Biosimilar insulin Glargine to make $100 m from FY18: Biocon

Realty reportcard: The flashback and road ahead for 2016

Godrej Prop's debt now halved due to BKC asset sale: CLSA

Godrej Prop sells its BKC project for Rs 1,479cr to Abbott